Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | Amcor PLC (AMCR) | XNYS | CH | 2024-06-30 | 3 days ago | USD | 9.12 | 5.92 | 64.97% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 132 | Accenture PLC (ACN) | XNYS | IE | 2024-08-31 | 3 days ago | USD | 307.90 | 105.66 | 34.32% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 133 | ACNB Corp (ACNB) | XNAS | US | 2024-12-31 | 3 days ago | USD | 42.84 | 55.51 | 129.58% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 134 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 1 year ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 135 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 3 days ago | USD | 4.84 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 136 | Ally Financial Inc (ALLY) | XNYS | US | 2024-12-31 | 3 days ago | USD | 34.61 | 57.31 | 165.60% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 137 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 1 year ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 138 | Allegion PLC (ALLE) | XNYS | IE | 2024-12-31 | 3 days ago | USD | 141.85 | 48.64 | 34.29% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 139 | Alerus Financial Corp (ALRS) | XNAS | US | 2024-12-31 | 3 days ago | USD | 21.27 | 22.69 | 106.66% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 140 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 3 days ago | USD | 0.29 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |